Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

BC030183 Activators

Akt Activators encompass a range of chemical compounds that enhance Akt signaling through various biochemical mechanisms. Growth factors like Insulin, IGF-1, PDGF, and EGF specifically activate their respective receptors, which subsequently stimulate phosphoinositide 3-kinase (PI3K) to produce phosphatidylinositol (3,4,5)-trisphosphate (PIP3). The generation of PIP3 is a critical step in recruiting Akt to the plasma membrane, where it is phosphorylated and activated by phosphoinositide-dependent kinase-1 (PDK1). Additionally, SC79 acts uniquely by binding directly to Akt, inducing its translocation to the plasma membrane, thereby facilitating its activation. Phosphatidic acid and spermine further enhance Akt activity by promoting its membrane translocation and phosphorylation, respectively. Meanwhile, resveratrol indirectly activates Akt by stimulating SIRT1, which deacetylates and activates LKB1, leading to downstream inhibition of TSC2, activation of the mTORC1 pathway, and subsequent Akt phosphorylation.

Sphingosine-1-phosphate, functioning through G-protein coupled receptors, initiates signaling cascades that ultimately promote Akt activation, while anisomycin, though primarily known as a protein synthesis inhibitor, can activate stress-activated kinases that lead to Akt activation. Hydrogen peroxide serves as a second messenger in oxidative signaling pathways, which can result in the inactivation of PTEN, a negative regulator of Akt, thus enhancing Akt signaling. Arachidonic acid, a fatty acid, may be metabolized into various bioactive lipids that can activate the PI3K/Akt pathway. Collectively, these chemical compounds activate Akt through direct interactions with Akt itself, by initiating receptor-mediated signaling cascades, or through modulating the activity of other proteins and lipids that converge on the critical node of Akt phosphorylation and activation.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Non-specific phosphodiesterase inhibitor that prevents cAMP degradation, potentially enhancing pathways that activate PKA, which in turn could phosphorylate and activate BC030183.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

A polyphenol that may inhibit certain kinases, potentially reducing competition for substrates or downstream signaling partners of BC030183.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that could alter AKT signaling, thereby affecting any downstream proteins including BC030183 that might be regulated by PI3K/AKT pathway.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Another PI3K inhibitor, similar to LY294002, which could modify downstream signaling affecting BC030183 activity.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

An MEK inhibitor which could alter ERK pathway signaling, possibly influencing BC030183 if it is involved in this pathway.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

A p38 MAPK inhibitor that could shift signaling dynamics in favor of pathways activating BC030183.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

An inhibitor of MEK1/2, which may lead to changes in signaling pathways that activate BC030183.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Activates PKC which could phosphorylate BC030183 if it is a PKC substrate.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A calcium ionophore that increases intracellular calcium levels, potentially activating calcium-dependent proteins and pathways that could include BC030183.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels that could activate pathways involving BC030183.